Tami Yap

university of melbourne

H指数:17

被引数:1,005

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Fatty acids-based compounds as novel prophylaxis or treatment for oropharyngeal Neisseria gonorrhoeae: an in vitro study

脂肪酸基化合物作为预防或治疗口咽部奈瑟氏淋病奈瑟菌的新方法：一项体外研究

Emerging Microbes & Infections

IF0

2026-06-090

Models of Oral Epithelial Dysplasia: A Systematic Review and Temporal Analysis

口腔上皮异常增生模型：系统综述与时间分析

JOURNAL OF ORAL PATHOLOGY & MEDICINE

IF2.3

2026-05-010

OAAI

Oral mucosal scrapes capture cancer associated microRNA expression consistent with histopathology

口腔黏膜刮片捕获与组织病理学一致的癌症相关microRNA表达

Scientific Reports

IF3.9

2026-03-250

OAAI

Ultralow Dose Rituximab Combined With IVIG Is Safe and Effective in Pemphigus Vulgaris: Single-Center Review of 24 Patients

极低剂量利妥昔单抗联合静脉注射免疫球蛋白在寻常型天疱疮中的安全性及有效性：单中心24例患者回顾研究

AUSTRALASIAN JOURNAL OF DERMATOLOGY

IF1.8

2025-11-010

PRE

Enabling high-resolution diagnostic oral confocal laser endomicroscopy in mice

实现小鼠高分辨率诊断性口腔共聚焦激光内窥镜成像

METHODS

IF4.3

2025-07-010

OAAI

The Role of Oral Yeasts in the Development and Progression of Oral Squamous Cell Carcinoma: A Scoping Review

口腔酵母在口腔鳞状细胞癌发生与发展中的作用：一项范围综述

JOURNAL OF FUNGI

IF4

2025-03-270

Convolutional neural networks for accurate real-time diagnosis of oral epithelial dysplasia and oral squamous cell carcinoma using high-resolution in vivo confocal microscopy

SCIENTIFIC REPORTS

IF3.9

2025-01-200

OAAI

Safety and Preliminary Efficacy of APR-1051, a WEE1 Inhibitor, in a Phase 1 Study of Patients with Cancer-Associated Gene Alterations (ACESOT-1051)

EUROPEAN JOURNAL OF CANCER

IF7.1

2024-10-010

PRE

Mouthwashes: Alternatives and Future Directions

INTERNATIONAL DENTAL JOURNAL

IF3.7

2023-11-014

The Role of Vitamins in Oral Potentially Malignant Disorders and Oral Cancer: A Systematic Review

维生素在口腔潜在恶性病变和口腔癌中的作用：系统综述

JOURNAL OF PERSONALIZED MEDICINE

IF3

2023-10-234

OAAI

Acquisition and annotation in high resolution in vivo digital biopsy by confocal microscopy for diagnosis in oral precancer and cancer

FRONTIERS IN ONCOLOGY

IF3.3

2023-07-033

OAAI

Fixed drug eruptions - the common and novel culprits since 2000

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT

IF3.8

2022-10-0913

PRE

Ultralow-dose rituximab in pemphigus: a single-centre experience

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2021-11-307

De-escalation of anti-CD20 monoclonal antibody (Rituximab) protocols in Pemphigus Vulgaris - a systematic review

寻常型天疱疮中anti-CD20单克隆抗体 (利妥昔单抗) 方案的降级-系统评价

EXPERT OPINION ON BIOLOGICAL THERAPY

IF4

2021-06-110

PREAI

Selinexor in combination with carboplatin and pemetrexed (CP) in patients with advanced or metastatic solid tumors: Results of an open label, single-center, multi-arm phase Ib study

ANNALS OF ONCOLOGY

IF65.4

2020-11-010

OAAI

Selinexor in combination with standard chemotherapy in patients with advanced solid tumours: Results of an open label, single-center, multi-arm phase Ib study

ANNALS OF ONCOLOGY

IF65.4

2020-11-010

OAAI

Kava constituents exert selective anticancer effects in oral squamous cell carcinoma cells in vitro

SCIENTIFIC REPORTS

IF3.9

2020-09-286

OAAI

Selinexor in combination with topotecan in patients with advanced or metastatic solid tumours: Results of an open label, single-center, multi-arm phase Ib study

ANNALS OF ONCOLOGY

IF65.4

2020-09-011

OAAI

Selinexor in combination with carboplatin and paclitaxel in patients with advanced or metastatic solid tumours: Results of an open label, single-center, multi-arm phase Ib study

ANNALS OF ONCOLOGY

IF65.4

2020-09-011

OAAI

Non-invasive screening of a microRNA-based dysregulation signature in oral cancer and oral potentially malignant disorders

ORAL ONCOLOGY

IF3.9

2019-09-0136

PREAI

Tami Yap

个人简介

教育背景

工作经历

荣誉奖项

研究方向